Progranulin regulates the development and function of NKT2 cells through EZH2 and PLZF

被引:5
作者
Du, Zuochen [1 ,2 ,3 ,4 ,5 ]
Huang, Lu [1 ,2 ,3 ,4 ]
Dai, Xin [6 ]
Yang, Di [1 ,2 ,3 ,4 ]
Niu, Linlin [1 ,2 ,3 ,4 ]
Miller, Heather [7 ]
Ruan, Changshun [1 ,2 ,3 ,4 ]
Li, Han [1 ,2 ,3 ,4 ]
Hu, Leling [1 ,2 ,3 ,4 ]
Zhou, Lijia [1 ,2 ,3 ,4 ]
Jian, Ding [1 ,2 ,3 ,4 ]
Sun, Jian [5 ]
Shi, Xiaoqi [5 ]
Huang, Pei [5 ]
Chen, Yan [5 ]
Zhao, Xiaodong [1 ,2 ,3 ,4 ]
Liu, Chaohong [1 ,2 ,3 ,4 ,6 ]
机构
[1] Chongqing Med Univ, Childrens Hosp, Chongqing Key Lab Child Infect & Immun, Chongqing, Peoples R China
[2] Chongqing Med Univ, Childrens Hosp, Res Inst, Dept Pediat, Chongqing, Peoples R China
[3] Chongqing Med Univ, Childrens Hosp, Minist Educ, Key Lab Child Dev & Disorder, Chongqing, Peoples R China
[4] Chongqing Med Univ, Childrens Hosp, Int Sci & Technol Cooperat Base Child Dev & Crit, Chongqing, Peoples R China
[5] Zunyi Med Univ, Affiliated Hosp, Dept Pediat 2, Zunyi, Guizhou, Peoples R China
[6] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Pathogen Biol, Wuhan, Peoples R China
[7] NIAID, Lab Intracellular Parasites, Rocky Mt Labs, NIH, Hamilton, MT USA
基金
中国国家自然科学基金;
关键词
GENE-EXPRESSION; PROTEIN; DIFFERENTIATION; ENHANCER; GROWTH; IL-4;
D O I
10.1038/s41418-022-00973-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
T helper 2 (Th2) cytokine production by invariant natural killer T (iNKT) cells is involved in the development of asthma, but the regulation of Th2 cytokines in iNKT cells remains unknown. Although it is known that progranulin (PGRN) induces the production of Th2 cytokines in iNKT cells in vivo, the underlying mechanism is not clear. This study aims to investigate the role of PGRN in iNKT cells. The effects of PGRN on the differentiation of iNKT cells was detected by flow cytometry. Then stimulation of iNKT cells and airway resistance were carried out to evaluate the function of PGRN on iNKT cells. Furthermore, the mechanisms of PGRN in regulating iNKT cells was investigated by RT-PCR, WB, confocal and luciferase reporter assays. The absolute number of iNKT cells decreased in PGRN KO mice despite an increase in the percentage of iNKT cells. Furthermore, analyzing the subsets of iNKT cells, we found that NKT2 cells and their IL-4 production were reduced. Mechanistically, the decrease in NKT2 cells in the PGRN KO mice was caused by increased expression of enhancer of zeste homolog 2 (EZH2), that in turn caused increased degradation and altered nuclear localization of PLZF. Interestingly, PGRN signaling decreased expression of EZH2 and treatment of the PGRN KO mice with the EZH2 specific inhibitor GSK343 rescued the defect in NKT2 differentiation, IL-4 generation, and PLZF expression. Altogether, We have revealed a new pathway (PGRN-EZH2-PLZF), which regulates the Th2 responses of iNKT cells and provides a potentially new target for asthma treatment.
引用
收藏
页码:1901 / 1912
页数:12
相关论文
共 50 条
  • [31] PCAF-primed EZH2 acetylation regulates its stability and promotes lung adenocarcinoma progression
    Wan, Junhu
    Zhan, Jun
    Li, Shuai
    Ma, Ji
    Xu, Weizhi
    Liu, Chang
    Xue, Xiaowei
    Xie, Yuping
    Fang, Weigang
    Chin, Y. Eugene
    Zhang, Hongquan
    [J]. NUCLEIC ACIDS RESEARCH, 2015, 43 (07) : 3591 - 3604
  • [32] A non-canonical function of Ezh2 preserves immune homeostasis
    Vasanthakumar, Ajithkumar
    Xu, Dakang
    Lun, Aaron T. L.
    Kueh, Andrew J.
    van Gisbergen, Klaas P. J. M.
    Iannarella, Nadia
    Li, Xiaofang
    Yu, Liang
    Wang, Die
    Williams, Bryan R. G.
    Lee, Stanley C. W.
    Majewski, Ian J.
    Godfrey, Dale I.
    Smyth, Gordon K.
    Alexander, Warren S.
    Herold, Marco J.
    Kallies, Axel
    Nutt, Stephen L.
    Allan, Rhys S.
    [J]. EMBO REPORTS, 2017, 18 (04) : 619 - 631
  • [33] Identification of Novel EZH2 Targets Regulating Osteogenic Differentiation in Mesenchymal Stem Cells
    Hemming, Sarah
    Cakouros, Dimitrios
    Vandyke, Kate
    Davis, Melissa J.
    Zannettino, Andrew C. W.
    Gronthos, Stan
    [J]. STEM CELLS AND DEVELOPMENT, 2016, 25 (12) : 909 - 921
  • [34] EZH2 modulates retinoic acid signaling to ensure myotube formation during development
    Thulabandu, Venkata
    Ferguson, James W.
    Phung, Melissa
    Atit, Radhika P.
    [J]. FEBS LETTERS, 2022, 596 (13) : 1672 - 1685
  • [35] EZH2 Mediates Proliferation, Migration, and Invasion Promoted by Estradiol in Human Glioblastoma Cells
    Del Moral-Morales, Aylin
    Gonzalez-Orozco, Juan Carlos
    Hernandez-Vega, Ana Maria
    Hernandez-Ortega, Karina
    Pena-Gutierrez, Karla Mariana
    Camacho-Arroyo, Ignacio
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [36] Characterization of Retinal Structure and Function in Mice Carrying Ezh2 Deficiency Specifically in Retinal Ganglion Cells
    Cheng, Lin
    Yu, Honghua
    Yan, Naihong
    Zhou, Honghao
    Chen, Dongfeng
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [37] The Polycomb Protein Ezh2 Regulates Differentiation and Plasticity of CD4+ T Helper Type 1 and Type 2 Cells
    Tumes, Damon J.
    Onodera, Atsushi
    Suzuki, Akane
    Shinoda, Kenta
    Endo, Yusuke
    Iwamura, Chiaki
    Hosokawa, Hiroyuki
    Koseki, Haruhiko
    Tokoyoda, Koji
    Suzuki, Yutaka
    Motohashi, Shinichiro
    Nakayama, Toshinori
    [J]. IMMUNITY, 2013, 39 (05) : 819 - 832
  • [38] USP44 Promotes the Tumorigenesis of Prostate Cancer Cells through EZH2 Protein Stabilization
    Park, Jae Min
    Lee, Jae Eun
    Park, Chan Mi
    Kim, Jung Hwa
    [J]. MOLECULES AND CELLS, 2019, 42 (01) : 17 - 27
  • [39] FoxP3 and Ezh2 regulate Tfr cell suppressive function and transcriptional program
    Hou, Shenda
    Clement, Rachel L.
    Diallo, Alos
    Blazar, Bruce R.
    Rudensky, Alexander Y.
    Sharpe, Arlene H.
    Sage, Peter T.
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2019, 216 (03) : 605 - 620
  • [40] EZH2 negatively regulates PD-L1 expression in hepatocellular carcinoma
    Xiao, Gang
    Jin, Li-Lian
    Liu, Chao-Qun
    Wang, Yong-Chun
    Meng, Ya-Ming
    Zhou, Zhong-Guo
    Chen, Jing
    Yu, Xing-Juan
    Zhang, Yao-Jun
    Xu, Jing
    Zheng, Limin
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7 (01):